Ansuman Satpathy studies how immune cells respond to cancer, combining immunology, genomics, and computation at Stanford. He co-founded several biotechnology companies, including Santa Ana Bio, and helps translate scientific discoveries into therapies as a venture partner at Wing.
Ansuman Satpathy studies how immune cells respond to cancer, combining immunology, genomics, and computation at Stanford. He co-founded several biotechnology companies, including Santa Ana Bio, and helps translate scientific discoveries into therapies as a venture partner at Wing.
Career
Board Member at Chemify from 2025-10 to PresentLCBoard Member at Link Cell Therapies from 2025-09 to Present
1GScientific Advisor at 10x Genomics from 2025-01 to Present
Associate Professor, Pathology and Immunology at Stanford University from 2024-04 to PresentABCo-Founder and Board Member at Arpelos Biosciences from 2024-01 to Present
Co-Founder at Santa Ana Bio from 2022-09 to Present
Venture Partner at Wing Venture Capital from 2021-11 to Present
Founder at Cartography Biosciences from 2020-10 to PresentICo-Founder at Immunai from 2018-10 to Present
Co-Director, Stanford Center at Parker Institute for Cancer Immunotherapy until PresentCosigns Received
Caleb Lareau
a great mentor like @Satpathology who launched this project in his lab